Annual general meeting has been held in SciBase Holding AB (publ)

For more information, please contact:Simon Grant, CEO SciBaseTel: +46 72 887 43 99Email: simon.grant@scibase.com For more information, please contact: Simon Grant, CEO SciBase Tel: +46 72 887 43 99 Email:simon.grant@scibase.com Certified Advisor (CA): Vator Securities  Tel: +46 8 580 065 99 Email:  ca@vatorsec.se About SciBase and Nevisense SciBase is a global medical technology company headquartered inStockholm, Sweden, that has developed a unique point of care...

For more information, please contact:
Simon Grant, CEO SciBase
Tel: +46 72 887 43 99
Email: simon.grant@scibase.com

Certified Advisor (CA):

Vator Securities 
Tel: +46 8 580 065 99
Email: ca@vatorsec.se

About SciBase and Nevisense

SciBase is a global medical technology company headquartered in Stockholm, Sweden, that has developed a unique point of care platform for the non-invasive detection of skin cancer and other skin conditions. SciBase is a pioneer within augmented intelligence, combining artificial intelligence with Electrical Impedance Spectroscopy (EIS) to provide objective information that assists dermatologists and others in clinical decision-making. SciBase's products include Nevisense and Nevisense Go and to date the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection and skin barrier assessment. Nevisense is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. SciBase's technology is based on more than 20 years of academic research at the Karolinska Institute in Stockholm, Sweden. For more information please visit www.scibase.com.  All press-releases and financial reports can be found here : http://investors.scibase.se/en/pressreleases

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/annual-general-meeting-has-been-held-in-scibase-holding-ab-publ-301827496.html